Cardiac Shock
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age Range: Above 18 years old; 2. Meeting the diagnostic criteria for cardiogenic shock: Presence of hypotensive manifestations and at least one sign of inadequate organ perfusion; 3. Hypotensive Manifestations: In the context of adequate blood volume, systolic blood pressure 2mmol/L; 5. Patients or their authorized representatives agree to participate in this study, sign a written informed consent form, and are willing to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients with clearly identified other causes of shock at admission (such as hemorrhage, trauma, medications, etc.) and assessed by the investigator to have non-cardiogenic causes as the primary reason for shock; 2. Patients undergoing continuous cardiopulmonary resuscitation for more than 60 minutes without the establishment of ECMO or other mechanical assistive support; 3. Patients with cardiogenic shock who have entered Stage E according to the SCAI staging system; 4. Individuals who have participated in other new drug clinical trials within the last 3 months; 5. Patients with psychiatric disorders, alcoholism, or abuse and dependency on psychoactive substances; 6. Patients with missing medical record information or physiological and chemical indicators; 7. Patients deemed unsuitable for participation in this study by the investigator; 8. Pregnant women, women planning to become pregnant, and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| all-cause mortality;cardiovascular death;Compound endpoint of adverse cardiovascular events (PCI driven by myocardial ischemia or hospitalization, readmission of recurrent myocardial infarction, stroke, heart failure); | — |
Secondary
| Measure | Time frame |
|---|---|
| End stage renal disease requires hemodialysis;hospital stay;Hospitalization expenses;Quality of life score; | — |
Countries
China
Contacts
Guangdong Provincial People's Hospital